Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New foam method may improve varicose vein treatment

NCT ID NCT06667570

Disease control Sponsor: Lidiane Rocha Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new method called SALFOAM 3% for treating varicose veins in the legs. It involved 35 adults and compared the new method to the standard foam treatment. The goal was to see if the new method closes veins better and causes less skin darkening.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

35 people

The number who actually took part.

Started

Oct 2024

Finished

Feb 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 years or older with clinically confirmed varicose veins in the lower limbs by ultrasonography. * All Fitzpatrick skin types (I-VI). * Ability to provide written informed consent. Exclusion Criteria: * Pregnancy or breastfeeding. * Known allergy or adverse reaction to polidocanol or similar agents. * Active infection in the area of treatment. * Immunosuppressed patients. * Severe coagulopathies or a history of recent deep vein thrombosis or pulmonary embolism. * Diagnosis of patent foramen ovale. * CEAP classification VI (active venous ulcers). * Use of medications that may interfere with the study outcomes. * Inability to comply with the study protocol or refusal to participate.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Varicose veins are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Hyperpigmentation varicose disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Varicose veins

Contacts and locations

Locations

  • Hospital São Luiz Gonzaga

    São Paulo, São Paulo, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.